Poseida Therapeutics, Inc. Annual Operating Margin in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Poseida Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2023.
  • Poseida Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -41.4 %, a 84.9% increase year-over-year.
  • Poseida Therapeutics, Inc. annual Operating Margin for 2023 was -200 %, a 336% decline from 2022.
  • Poseida Therapeutics, Inc. annual Operating Margin for 2022 was -45.9 %, a 89.9% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -200 -154 -336% Jan 1, 2023 Dec 31, 2023
2022 -45.9 +407 +89.9% Jan 1, 2022 Dec 31, 2022
2021 -453 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.